ArticleJournal of tropical pediatrics2026
A 13-year cohort study using clinical machine learning to differentiate bacterial and viral infections in young infants in a dengue hyperendemic region.
Article in Journal of tropical pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Differentiating bacterial from viral infections in febrile young infants is challenging, particularly in dengue-hyperendemic regions. We developed and internally validated a clinical machine-learning model to enhance diagnostic accuracy in this risk population in Colombia. We retrospectively analyzed a pediatric infectious admission cohort (<18 years) at a reference hospital in southern Colombia from 2007 to 2019. 4671 admissions (2251 bacterial and 2420 viral) were included. Nine clinical and laboratory variables were used to train an eXtreme Gradient Boosting (XGBoost) classifier. We divided the data into development (70%) and test (30%) sets, with Youden's J statistics defining the optimal threshold. Penalized logistic regression (LR) and single-marker rules [leukocytosis, C-reactive protein (CRP)] served as comparators. The young-infant XGBoost achieved an area under the receiver-operating characteristic curve (AUC) of 0.896, outperforming LR (0.790) and single markers (0.746-0.706). Sensitivity was 93.5%, specificity 76.1%, positive predictive value 87.9%, and negative predictive value 86.4% in the temporal validation cohort. Discrimination was highest in children aged 6-10 years (AUC 0.967). CRP positivity, leukocytosis >16 × 10³ µl-1, and thrombocytopenia <150 × 10³ µl-1 were the most informative features. A nine-variable XGBoost model using routine clinical and hematologic variables accurately differentiated bacterial from viral infections in children from a low-resource dengue-endemic setting. Performance remained stable during temporal validation. Improved specificity with preserved sensitivity supports earlier targeted therapy and antibiotic stewardship. Multicenter studies and exploration of clinical challenges are the next steps for this kind of tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.